ArticleThe Journal of international medical research2016
Clinical features and biological markers of lung cancer-associated stroke.
Article in The Journal of international medical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- Development of an algorithm for identifying paraneoplastic ischemic stroke in association with lung, pancreatic, and colorectal cancer.Therapeutic advances in neurological disorders · 2024Article
- Article
- Clinical impact of cerebral infarction in patients with non-small cell lung cancer.International journal of clinical oncology · 2022Article
- Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.Internal and emergency medicine · 2022Article
- Trousseau's Syndrome Presenting as Multiple Cerebral Infarctions Caused by Mucin-producing Bladder Micropapillary Urothelial Cancer.Internal medicine (Tokyo, Japan) · 2022Article
- Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach.Therapeutic advances in neurological disorders · 2022Review
- Clinical practice: intravenous thrombolysis in a patient with active cancer who experienced wake-up stroke.The Journal of international medical research · 2021Article
- Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.World journal of gastrointestinal surgery · 2020Review
- Independent risk factors and the potential predictors of bladder cancer-related ischemic stroke.The Journal of international medical research · 2020Article
- The biomarkers and potential pathogenesis of lung cancer related cerebral hemorrhage.Medicine · 2019Observational
- Cancer-associated stroke: Pathophysiology, detection and management (Review).International journal of oncology · 2019Review
- Clinical Characteristics and Risk Factors of Lung Cancer-Associated Acute Ischemic Stroke.BioMed research international · 2019Article
- Lung Adenocarcinoma Presenting as Multiple Thromboembolic Events: A Case Report and Review of the Literature.Journal of investigative medicine high impact case reportsReview
- Anticoagulants for cancer-associated ischemic stroke.Tzu chi medical journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective To identify the unique clinical features and biological markers of lung cancer-associated stroke. Methods We recruited 102 patients with lung cancer plus stroke, 102 with lung cancer, and 102 with stroke. Detailed information was analysed and compared among groups. Results The groups were age-matched. Patients with lung cancer plus stroke showed multiple lesions involving multiple cerebral artery territories on magnetic resonance imaging, compared with stroke-alone patients. These patients also had a poorer modified Rankin Scale score at 30 days, and high mortality (18.6%). Patients with lung cancer plus stroke had a higher incidence of metastasis, and higher blood levels of D-dimer, CA125 and CA199 compared with patients with lung cancer alone. Multivariate logistic regression analysis showed that levels of D-dimer, CA125 and CA199 were independently related to lung cancer-associated stroke. Conclusion Elevated plasma D-dimer, CA125 and CA199 may be independent risk factors for and biomarkers of lung cancer-associated stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.